Developing Effective and Efficient care pathways in chronic Pain: DEEP study protocol

BMC Oral Health

Luke Vale²  Jimmy Steele¹  Catherine Exley²  Vera Araujo-Soares²  Matthew Breckons²  Justin Durham¹ 

[1] Centre for Oral Health Research (COHR), Newcastle University, Newcastle upon Tyne, UK;Institute of Health & Society, Newcastle University, Baddiley-Clark Building, Richardson Road, Newcastle upon Tyne NE2 4AX, UK

关键词: Care pathways;    Chronic pain;    Qualitative methods;    Quality of life;    Health economics;    Orofacial pain;   

Others  :  1121487
DOI  :  10.1186/1472-6831-14-6

 received in 2013-12-17, accepted in 2014-01-13,  发布年份 2014

【 摘 要 】

Background

Pain affecting the face or mouth and lasting longer than three months (“chronic orofacial pain”, COFP) is relatively common in the UK. This study aims to describe and model current care pathways for COFP patients, identify areas where current pathways could be modified, and model whether these changes would improve outcomes for patients and use resources more efficiently.

Methods/Design

The study takes a prospective operations research approach. A cohort of primary and secondary care COFP patients (n = 240) will be recruited at differing stages of their care in order to follow and analyse their journey through care. The cohort will be followed for two years with data collected at baseline 6, 12, 18, and 24 months on: 1) experiences of the care pathway and its impacts; 2) quality of life; 3) pain; 4) use of health services and costs incurred; 5) illness perceptions. Qualitative in-depth interviews will be used to collect data on patient experiences from a purposive sub-sample of the total cohort (n = 30) at baseline, 12 and 24 months. Four separate appraisal groups (public, patient, clincian, service manager/commissioning) will then be given data from the pathway analysis and asked to determine their priority areas for change. The proposals from appraisal groups will inform an economic modelling exercise. Findings from the economic modelling will be presented as incremental costs, Quality Adjusted Life Years (QALYs), and the incremental cost per QALY gained. At the end of the modelling a series of recommendations for service change will be available for implementation or further trial if necessary.

Discussion

The recent white paper on health and the report from the NHS Forum identified chronic conditions as priority areas and whilst technology can improve outcomes, so can simple, appropriate and well-defined clinical care pathways. Understanding the opportunity cost related to care pathways benefits the wider NHS. This research develops a method to help design efficient systems built around one condition (COFP), but the principles should be applicable to a wide range of other chronic and long-term conditions.

【 授权许可】

   
2014 Durham et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Aggarwal VR, Joughin A, Zakrzewska J, Appelbe P, Tickle M: Dentist’s preferences for diagnosis, management and referral of chronic oro-facial pain: results from a national survey. Health Educ J 2012, 71:662-669.
• [2]Aggarwal VR, Joughin A, Zakrzewska JM, Crawford FJ, Tickle M: Dentists’ and specialists’ knowledge of chronic orofacial pain: results from a continuing professional development survey. Prim Dent Care 2011, 18:41-44.
• [3]Durham J, Exley C, Wassell R, Steele JG: ‘Management is a black art’–professional ideologies with respect to temporomandibular disorders. Br Dent J 2007, 202:E29. discussion 682–3
• [4]Kristiansson MH, Brorsson A, Wachtler C, Troein M: Pain, power and patience - a narrative study of general practitioners’ relations with chronic pain patients. BMC Fam Pract 2011, 12:31. BioMed Central Full Text
• [5]Durham J, Steele JG, Wassell RW, Exley C: Living with uncertainty: temporomandibular disorders. J Dent Res 2010, 89:827-830.
• [6]Durham J, Steele J, Moufti MA, Wassell R, Robinson P, Exley C: Temporomandibular disorder patients’ journey through care. Community Dent Oral Epidemiol 2011, 39:532-541.
• [7]Nilsson IM, List T, Willman A: Adolescents with temporomandibular disorder pain-the living with TMD pain phenomenon. J Orofac Pain 2011, 25:107-116.
• [8]Wolf E, Birgerstam P, Nilner M, Petersson K: Nonspecific chronic orofacial pain: studying patient experiences and perspectives with a qualitative approach. J Orofac Pain 2008, 22:349-358.
• [9]Wolf E, Birgerstam P, Nilner M, Petersson K: Patients’ experiences of consultations for nonspecific chronic orofacial pain: a phenomenological study. J Orofac Pain 2006, 20:226-233.
• [10]Hasanain F, Durham J, Moufti A, Steen IN, Wassell RW: Adapting the diagnostic definitions of the RDC/TMD to routine clinical practice: a feasibility study. J Dent 2009, 37:955-962.
• [11]Meloto CB, Serrano PO, Ribeiro-DaSilva MC, Rizzatti-Barbosa CM: Genomics and the new perspectives for temporomandibular disorders. Arch Oral Biol 2011, 56:1181-1191.
• [12]Beecroft EV, Durham J, Thomson P: Retrospective examination of the healthcare ‘journey’ of chronic orofacial pain patients referred to oral and maxillofacial surgery. Br Dent J 2013, 214:E12.
• [13]Aggarwal VR, McBeth J, Zakrzewska JM, Macfarlane GJ: Unexplained orofacial pain - is an early diagnosis possible? Br Dent J 2008, 205:E6. discussion 140–1
• [14]Glaros AG, Glass EG, Hayden WJ: History of treatment received by patients with TMD: a preliminary investigation. J Orofac Pain 1995, 9:147-151.
• [15]Shimshak DG, Kent RL, DeFuria M: Medical claims profiles of subjects with temporomandibular joint disorders. Cranio 1997, 15:150-158.
• [16]Shimshak DG, DeFuria MC: Health care utilization by patients with temporomandibular joint disorders. Cranio 1998, 16:185-193.
• [17]White BA, Williams LA, Leben JR: Health care utilization and cost among health maintenance organization members with temporomandibular disorders. J Orofac Pain 2001, 15:158-169.
• [18]Suvinen TI, Reade PC, Kemppainen P, Kononen M, Dworkin SF: Review of aetiological concepts of temporomandibular pain disorders: towards a biopsychosocial model for integration of physical disorder factors with psychological and psychosocial illness impact factors. Eur J Pain 2005, 9:613-633.
• [19]Phillips C, Main C, Buck R, Aylward M, Wynne-Jones G, Farr A: Prioritising pain in policy making: the need for a whole systems perspective. Health Policy 2008, 88:166-175.
• [20]Donaldson L: Pain: Breaking through the Barrier. 150 years of the Annual Report of the Chief Medical Officer: On the state of Public Health 2008, 32-39.
• [21]National pain audit. Final report 2010–2012 [http://www.nationalpainaudit.org/media/files/NationalPainAudit-2012.pdf webcite]
• [22]Kerns RD, Turk DC, Rudy TE: The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985, 23:345-356.
• [23]Von Korff M, Dunn KM: Chronic pain reconsidered. Pain 2008, 138:267-276.
• [24]Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5 L). Qual Life Res 2011, 20:1727-1736.
• [25]Wordsworth S, Thompson S: An annotated cost questionnaire for patients: results of piloting. HERU Dicussion Paper 2001., 03/01
• [26]Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D: The revised illness perception questionnaire (IPQ-R). Psychol Health 2002, 17:1-16.
• [27]English indices of deprivation 2010 [https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/6871/1871208.pdf webcite]
• [28]Cohen J: Statistical Power Analysis for the Behavioral Sciences (2nd ed). New Jersey: Lawrence Erlbaum; 1988.
• [29]IASP classification of chronic pain: introduction Pain 1986, 24(Supplement 1):S3-S8.
• [30]Gonzalez YM, Schiffman E, Gordon SM, Seago B, Truelove EL, Slade G, Ohrbach R: Development of a brief and effective temporomandibular disorder pain screening questionnaire: reliability and validity. J Am Dent Assoc 2011, 142:1183-1191.
• [31]Hapak L, Gordon A, Locker D, Shandling M, Mock D, Tenenbaum HC: Differentiation between musculoligamentous, dentoalveolar, and neurologically based craniofacial pain with a diagnostic questionnaire. J Orofac Pain 1994, 8:357-368.
• [32]Smith BH, Penny KI, Purves AM, Munro C, Wilson B, Grimshaw J, Chambers WA, Smith WC: The chronic pain grade questionnaire: validation and reliability in postal research. Pain 1997, 71:141-147.
• [33]Sniehotta FF, Gorski C, Araujo-Soares V: Adoption of community-based cardiac rehabilitation programs and physical activity following phase III cardiac rehabilitation in Scotland: a prospective and predictive study. Psychol Health 2010, 25:839-854.
• [34]Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317-325.
• [35]Kroenke K, Spitzer RL, Williams JB, Lowe B: An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009, 50:613-621.
• [36]Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brahler E: A 4-item measure of depression and anxiety: validation and standardization of the patient health questionnaire-4 (PHQ-4) in the general population. J Affect Disord 2010, 122:86-95.
• [37]Glaser BG: The constant comparative method of qualitative analysis. Soc Probl 1965, 12:436-445.
• [38]Curtis L: Unit Costs of Health and Social Care. Kent: Personal Social Services Research Unit; 2012. [http://www.pssru.ac.uk/project-pages/unit-costs/ webcite]
• [39]British national formulary [http://www.bnf.org/bnf/index.htm webcite]
• [40]van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS: Interim scoring for the EQ-5D-5 L: mapping the EQ-5D-5 L to EQ-5D-3 L value sets. Value Health 2012, 15:708-715.
• [41]Kind P, Dolan P, Gudex C, Williams A: Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998, 316:736-741.
• [42]The role of the EuroQOL instrument in QALY calculations [http://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20130.pdf webcite]
• [43]Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J: Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004, 8:1-158. iii-iv, ix-xi
• [44]Guide to the methods of technology appraisal [http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9 webcite]
• [45]Durham J, Exley C, John MT, Nixdorf DR: Persistent dentoalveolar pain: the patient’s experience. J Orofac Pain 2013, 27:6-13.
• [46]Garro LC: Narrative representations of chronic illness experience: cultural models of illness, mind, and body in stories concerning the temporomandibular joint (TMJ). Soc Sci Med 1994, 38:775-788.
• [47]Epker J, Gatchel RJ, Ellis E: A model for predicting chronic TMD: practical application in clinical settings. J Am Dent Assoc 1999, 130:1470-1475.
• [48]Garofalo JP, Gatchel RJ, Wesley AL, Ellis E 3rd: Predicting chronicity in acute temporomandibular joint disorders using the research diagnostic criteria. J Am Dent Assoc 1998, 129:438-447.
• [49]Wright AR, Gatchel RJ, Wildenstein L, Riggs R, Buschang P, Ellis E: Biopsychosocial differences between high-risk and low-risk patients with acute TMD-related pain. J Am Dent Assoc 2004, 135:474-483.
• [50]Greene CS: Managing the care of patients with temporomandibular disorders: a new guideline for care. J Am Dent Assoc 2010, 141:1086-1088.
• [51]Woolf CJ: Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011, 152:S2-15.
• [52]Anderson GC, John MT, Ohrbach R, Nixdorf DR, Schiffman EL, Truelove ES, List T: Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain. Pain 2011, 152:765-771.
• [53]Cady RJ, Glenn JR, Smith KM, Durham PL: Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization. Mol Pain 2011, 7:94. BioMed Central Full Text
• [54]Fernandez-de-las-Penas C, Galan-del-Rio F, Fernandez-Carnero J, Pesquera J, Arendt-Nielsen L, Svensson P: Bilateral widespread mechanical pain sensitivity in women with myofascial temporomandibular disorder: evidence of impairment in central nociceptive processing. J Pain 2009, 10:1170-1178.
• [55]Lorduy KM, Liegey-Dougall A, Haggard R, Sanders CN, Gatchel RJ: The prevalence of comorbid symptoms of central sensitization syndrome among three different groups of temporomandibular disorder patients. Pain Pract 2013, 2013:604-613.
• [56]Mohn C, Vassend O, Knardahl S: Experimental pain sensitivity in women with temporomandibular disorders and pain-free controls: the relationship to orofacial muscular contraction and cardiovascular responses. Clin J Pain 2008, 24:343-352.
• [57]Xu W, Wu Y, Bi Y, Tan L, Gan Y, Wang K: Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats. Mol Pain 2010, 6:49. BioMed Central Full Text
• [58]Maixner W, Greenspan JD, Dubner R, Bair E, Mulkey F, Miller V, Knott C, Slade GD, Ohrbach R, Diatchenko L, Fillingim RB: Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case–control study. J Pain 2011, 12:T75-91.
• [59]Dodick D, Silberstein S: Central sensitization theory of migraine: clinical implications. Headache 2006, 46(Suppl 4):S182-91.
• [60]Gardea MA, Gatchel RJ: Interdisciplinary treatment of chronic pain. Curr Rev Pain 2000, 4:18-23.
• [61]Robbins H, Gatchel RJ, Noe C, Gajraj N, Polatin P, Deschner M, Vakharia A, Adams L: A prospective one-year outcome study of interdisciplinary chronic pain management: compromising its efficacy by managed care policies. Anesth Analg Anesth Analg 2003, 97:156-162.
• [62]Equity and excellence: liberating the NHS [http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_117794.pdf webcite]